M8891
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M8891, covering 2022-03-11 to 2022-03-11. Get the full timeline:
Most recent: Clinical Trial Update: M8891 First in Human in Solid Tumors [Phase 1]
1 regulatory and trial event tracked for M8891, covering 2022-03-11 to 2022-03-11. Get the full timeline:
Most recent: Clinical Trial Update: M8891 First in Human in Solid Tumors [Phase 1]